Serum Institute gets nod for resumption of Oxford vax trials
NEW DELHI: The Serum Institute of India has received approval from the Drugs Controller General of India (DCGI) to resume the clinical trial of the Oxford Covid-19 vaccine candidate, officials from the drug manufacturing company confirmed on Wednesday. India is the manufacturing partner of the vaccine candidate named Covishield, developed jointly by the University of […]